Page Title
Clinical Trial Finder
Observational Closed to Enrollment
Sweat chloride observational study (CHEC-OB-17)
This study is taking place at multiple care centers across the U.S. It will look at sweat chloride concentration in people who are currently taking CFTR modulators.
Researchers will test the effectiveness of CFTR modulators by measuring change in sweat chloride concentration. Sweat chloride measures that are collected in the study visit will be analyzed in combination with data from the CF Foundation Patient Registry.This study is for people with cystic fibrosis who are enrolled in the CF Foundation Patient Registry and have been taking a CFTR modulator for at least three months before enrolling. This study will consist of a single study visit and will require a sweat test.
Eligibility
See other primary eligibility criteria for more information.
-
Age:
4 Months and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Other Primary Eligibility Criteria
Study participants must have current treatment with a commercially approved CFTR modulator for at least 3 months prior to enrollment.
Study Design
-
Study Type: ?more info
Observational -
Randomized Study: ?more info
No -
Placebo Controlled: ?more info
No -
Length of Participation:
1 days -
Number of Study Visits:
1
Additional Information
-
Phase: ?more info
Not Applicable -
Study Sponsor: ?more info
Hamblett, Nicole -
Study Drugs:
N/A
Study Sites
-
Closed to Enrollment
Alabama
The Children's Hospital Alabama, University of Alabama at Birmingham, Birmingham, AL 35233
-
Closed to Enrollment
Arkansas
University of Arkansas for Medical Sciences, Little Rock, AR 72205
-
Closed to Enrollment
California
University of California San Diego, La Jolla, CA 92093
-
Closed to Enrollment
California
Children's Hospital of Los Angeles, Los Angeles, CA 90027
-
Closed to Enrollment
Colorado
Children's Hospital Colorado, Aurora, CO 80045
-
Closed to Enrollment
Colorado
National Jewish Health, Denver, CO 80206
-
Closed to Enrollment
Connecticut
Yale University School of Medicine, New Haven, CT 06520
-
Closed to Enrollment
Florida
University of Florida, Gainesville, FL 32610
-
Closed to Enrollment
Florida
The Nemours Children's Clinic - Orlando, Orlando, FL 32827
-
Closed to Enrollment
Florida
Nemours Children's Health - Pensacola, Pensacola, FL 32514
-
Closed to Enrollment
Georgia
Children’s Healthcare of Atlanta and Emory University, Atlanta, GA 30322
-
Closed to Enrollment
Georgia
Emory University, Atlanta, GA 30324
-
Closed to Enrollment
Illinois
Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL 60611
-
Closed to Enrollment
Illinois
University of Chicago, Chicago, IL 60637
-
Closed to Enrollment
Indiana
Riley Hospital for Children, Indianapolis, IN 46202
-
Closed to Enrollment
Kansas
University of Kansas Medical Center, Kansas City, KS 66160
-
Closed to Enrollment
Kentucky
University of Kentucky, Lexington, KY 40506
-
Closed to Enrollment
Maryland
Johns Hopkins University, Baltimore, MD 21287
-
Closed to Enrollment
Massachusetts
Boston Children's Hospital, Boston, MA 02115
-
Closed to Enrollment
Massachusetts
Massachusetts General Hospital, Boston, MA 02114
-
Closed to Enrollment
Michigan
Corewell Health Helen DeVos, Grand Rapids , MI 49503
-
Closed to Enrollment
Michigan
University of Michigan, Michigan Medicine, Ann Arbor, MI 48109
-
Closed to Enrollment
Michigan
Children's Hospital of Michigan, Detroit, MI 48201
-
Closed to Enrollment
Minnesota
The Minnesota Cystic Fibrosis Center, Minneapolis, MN 55455
-
Closed to Enrollment
Missouri
Children's Mercy Kansas City, Kansas City, MO 64108
-
Closed to Enrollment
Missouri
St. Louis Children's Hospital, St. Louis, MO 63110
-
Closed to Enrollment
Missouri
SSM Health Cardinal Glennon Children’s Hospital, St. Louis, MO 63104
-
Closed to Enrollment
New Hampshire
Dartmouth Hitchcock Medical Center, Lebanon, NH 03756
-
Closed to Enrollment
New York
New York Medical College at Westchester Medical Center, Valhalla, NY 10595
-
Closed to Enrollment
New York
The Cystic Fibrosis Center of Western New York, Buffalo, NY 14203
-
Closed to Enrollment
North Carolina
University of North Carolina at Chapel Hill, Chapel Hill, NC 27514
-
Closed to Enrollment
Ohio
Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229
-
Closed to Enrollment
Ohio
Children's Hospital Medical Center of Akron, Akron, OH 44308
-
Closed to Enrollment
Ohio
Toledo Children's Hospital, Toledo, OH 43606
-
Closed to Enrollment
Ohio
Rainbow Babies and Children's Hospital/University Hospitals Cleveland Medical Center, Cleveland, OH 44106
-
Closed to Enrollment
Ohio
Nationwide Children's Hospital, Columbus, OH 43205
-
Closed to Enrollment
Oregon
Oregon Health & Science University, Portland, OR 97239
-
Closed to Enrollment
Pennsylvania
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224
-
Closed to Enrollment
Pennsylvania
Children's Hospital of Philadelphia, Philadelphia, PA 19104
-
Closed to Enrollment
Pennsylvania
Hershey Medical Center Pennsylvania State University, Hershey, PA 17033
-
Closed to Enrollment
South Carolina
Medical University of South Carolina, Charleston, SC 29425
-
Closed to Enrollment
Tennessee
Vanderbilt Children's Hospital, Nashville, TN 37232
-
Closed to Enrollment
Tennessee
University of Tennessee CF Care and Research Center, Memphis, TN 38103
-
Closed to Enrollment
Texas
Baylor College of Medicine, Houston, TX 77030
-
Closed to Enrollment
Texas
University of Texas Southwestern / Children’s Health, Dallas, TX 75207
-
Closed to Enrollment
Texas
University of Texas Southwestern, Dallas, TX 75390
-
Closed to Enrollment
Utah
Primary Children's Cystic Fibrosis Center, Salt Lake City, UT 84113
-
Closed to Enrollment
Washington
University of Washington Medical Center, Seattle, WA 98195
-
Closed to Enrollment
Washington
Seattle Children's Hospital, Seattle, WA 98105
-
Closed to Enrollment
West Virginia
West Virginia University - Morgantown, Morgantown, WV 26507
-
Closed to Enrollment
Wisconsin
Children's Wisconsin, Milwaukee, WI 53226
-
Closed to Enrollment
Wisconsin
University of Wisconsin, Madison, WI 53792
Eligibility
See other primary eligibility criteria for more information.
-
Age:
4 Months and Older -
Mutation(s):
No Mutation Requirement -
FEV1% Predicted:
No FEV1 Limit
For more information about the results of this study and where it was conducted, visit ClinicalTrials.gov.
Other Primary Eligibility Criteria
Study participants must have current treatment with a commercially approved CFTR modulator for at least 3 months prior to enrollment.
CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More